Atreca Inc (BCEL)
US$ 0.26-13.33%
Price Chart
Key Statistics
Market Cap
$ 3.57M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
4.09M
52W High
$ 0.10
52W Low
$ 0.07
Dividend Yield
0.00%
Beta
1.03
Technicals
50-Day MA
0.0878
200-Day MA
0.195
52 Week High
0.095
52 Week Low
0.075
About BCEL
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types.
Employees
90
Headquarters
South San Francisco, CA
CEO
Mr. John A. Orwin M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg